Effects of Fluid Therapy on Peripheral TIssse Perfusion During Sepsis/Septic Shock (NCT05094856) | Clinical Trial Compass
CompletedNot Applicable
Effects of Fluid Therapy on Peripheral TIssse Perfusion During Sepsis/Septic Shock
France61 participantsStarted 2022-02-23
Plain-language summary
Compare the effect of volume expansion by saline versus albumin on the correction of peripheral tissue hypoperfusion by measuring Index skin recoloration time (CRT) at H0 and H1
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age\> 18 years old
* Sepsis or
* Septic shock within 24 hours of admission to intensive care with a stable dose of norepinephrine for at least 2 hours to maintain MAP\> 65mmHg
* CRT index\> 3 seconds despite the initial resuscitation (administration of antibiotics, volume expansion by crystalloids of 20 mL / Kg, noradrenaline started) between the admission to intensive care and H48 from admission to intensive care
* Non-opposition of the patient collected by the doctor in charge of the patient between H0 and H6 after admission if the patient is vigilant, otherwise a procedure for collecting non-opposition from relatives will be carried out with collection of the non-opposition of the patient once he is able to give it.
* Affiliation to a social security regimen (excluding AME)
Exclusion Criteria:
* Patient COVID-19 (+) with respiratory impairment
* Pregnant and lactating woman
* Patient under Guardianship / Curatorship
* Refusal to participate
* CRT not evaluable (dark or damaged skin)
* Moribund patient
* Estimated life expectancy less than 1 month
* Participation in another interventional research involving the human person or period of exclusion at the end of a previous research involving the human person
What they're measuring
1
Compare the effect of volume expansion by saline versus albumin on the correction of peripheral tissue hypoperfusion by measuring Index skin recoloration time (CRT) at H0 and H1